Literature DB >> 7843525

Focus groups: a method for developing consensus guidelines in general practice.

H J Fardy1, D Jeffs.   

Abstract

The measurement of quality in any clinical discipline depends, in part, on a comparison with an accepted standard. Currently, such standards do not exist for the management of many common clinical situations in Australian general practice. As part of the General Practice Evaluation Programme, a group of Illawarra general practitioners (GPs) selected 'GP management of the menopause and asthma' for in-depth study, and were able to arrive at a consensus on 'principles of practice' and 'minimal acceptable care' for these conditions through a series of focus (research) group meetings. However, the process by which these standards were derived was felt, of itself, to be a valuable means of: (i) reducing professional isolation; (ii) promoting quality assurance; (iii) introducing peer review; (iv) introducing clinical audit; and (v) providing meaningful and targeted continuing medical education appropriate to Australian general practice. This paper describes the focus group methodology used in this process.

Entities:  

Mesh:

Year:  1994        PMID: 7843525     DOI: 10.1093/fampra/11.3.325

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  3 in total

1.  Development and evaluation of a quality assessment instrument for occupational physicians.

Authors:  W E van der Weide; J H Verbeek; F J van Dijk; C T Hulshof
Journal:  Occup Environ Med       Date:  1998-06       Impact factor: 4.402

Review 2.  A novel method of guideline development for the diagnosis and management of mild to moderate hypertension.

Authors:  J L Adams; D A Fitzmaurice; C M Heath; R F Loudon; A Riaz; A Sterne; C P Thomas
Journal:  Br J Gen Pract       Date:  1999-03       Impact factor: 5.386

3.  Quality of care from the patients' perspective: from theoretical concept to a new measuring instrument.

Authors:  Herman J. Sixma; Jan J. Kerssens; Crétien Van Campen; Loe Peters
Journal:  Health Expect       Date:  1998-11       Impact factor: 3.377

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.